Share this article
FSP or full-service: it is one of the first questions a biotech faces when clinical operations starts consuming real budget, and one of the least clearly explained. This guide breaks down what each model actually means, how Germany and Switzerland change the calculation, and what to look for in a CRO partner beyond the sales deck. If you are running or planning a DACH study, the decision is worth getting right before the contract is signed.